Viewing Study NCT00290004

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2025-12-31 @ 3:19 AM
Study NCT ID: NCT00290004
Status: COMPLETED
Last Update Posted: 2008-09-11
First Post: 2006-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: Pharmacyclics LLC.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Small Lymphocytic Lymphoma View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Lymphocytic Leukemia View
None Small Lymphocytic Lymphoma View
None Leukemia View
None Lymphoma View
None Motexafin Gadolinium View
None Relapsed Chronic Lymphocytic Leukemia View
None Relapsed Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Refractory Small Lymphocytic Lymphoma View